Suppr超能文献

老年女性(新西兰)口服避孕药的使用与患乳腺癌风险

Oral contraceptive use and risk of breast cancer in older women (New Zealand).

作者信息

Paul C, Skegg D C, Spears G F

机构信息

Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand.

出版信息

Cancer Causes Control. 1995 Nov;6(6):485-91. doi: 10.1007/BF00054155.

Abstract

The effect of oral contraceptive (OC) use at older ages on the risk of breast cancer was examined in a national population-based case-control study conducted in New Zealand. A total of 891 women aged 25 to 54 years with a first diagnosis of breast cancer, and 1,864 control subjects, randomly selected from the electoral rolls, were interviewed. The relative risk (RR) of breast cancer for women aged 45 to 54 years at diagnosis who had ever used OCs was 1.0 (95 percent confidence interval [CI] = 0.77-1.3). There was no significant increase in risk of breast cancer among recent users of OCs of any age. Analyses according to age at first and last use among women aged 40 years and older at diagnosis showed no group with an elevated risk of breast cancer. Women who had used OCs for 10 years or longer after age 40 had an apparent increase in risk (RR = 2.7, CI = 0.97-7.5), but the trend in risk with duration of use was not significant. These findings suggest that OC use in older women does not affect their risk of breast cancer appreciably, but it is not possible to rule out a modest increase in risk with such use.

摘要

在新西兰开展的一项基于全国人口的病例对照研究中,调查了大龄女性使用口服避孕药(OC)对患乳腺癌风险的影响。研究共访谈了891名首次诊断为乳腺癌的25至54岁女性,以及从选民名单中随机选取的1864名对照对象。诊断时年龄在45至54岁且曾使用过OC的女性患乳腺癌的相对风险(RR)为1.0(95%置信区间[CI]=0.77 - 1.3)。任何年龄段近期使用OC的女性患乳腺癌风险均未显著增加。对诊断时年龄在40岁及以上女性按首次和末次使用年龄进行分析,未发现患乳腺癌风险升高的组。40岁后使用OC达10年或更长时间的女性风险有明显增加(RR = 2.7,CI = 0.97 - 7.5),但风险随使用时长的变化趋势并不显著。这些发现表明,大龄女性使用OC对其患乳腺癌风险的影响不明显,但不能排除使用OC会使风险有适度增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验